Skip links

A question of balance – do health benefits outweigh possible harms?

Written by Barnaby Page || 30th January 2018 || Regulatory reports |

North America
United States
Public Health and Medicine
Regulation and Legislation
Regulatory reports
Given the complexity of all the possibilities, how can you forecast the long-term effect of e-cigs on smoking-related harms? That was the challenge taken on by the National Academies of Sciences, Engineering, and Medicine (NASEM) ...

FDA committee rejects two IQOS MRTP claims, approves one

Written by Barnaby Page || 25th January 2018 || Regulatory briefing |

United States
Companies
Marketing and Retailing
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction...

E-cigarette industry and regulation: trackers and databases

Written by Barnaby Page || 1st January 2018 || Databases , Regulatory trackers |

Africa
Asia
Australasia
EU
Europe
France
Germany
Italy
North America
South America
United Kingdom
United States
Market Research
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Databases
Regulatory trackers
ECigIntelligence’s trackers and databases provide a powerful, flexible way to find information on the e-cigarette industry and its regulation around the globe. Simply select your area of interest to get...

Global health group calls for HnB restrictions until science is proven

Written by Barnaby Page || 19th December 2017 || Regulatory briefing |

World
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
The International Union Against Tuberculosis and Lung Disease has called for the advertising and indoor use of heat-not-burn (HnB) products to be banned until sufficient independent research has been conducted to confirm their safety ...

Reynolds asks FDA to give Camel Snus products ‘modified risk’ status

Written by Barnaby Page || 19th December 2017 || Regulatory briefing |

North America
United States
Companies
Marketing and Retailing
Regulation and Legislation
Regulatory briefing
R. J. Reynolds has submitted modified risk tobacco product applications (MRTPAs) to the US FDA for six forms of its Camel Snus product, which it is seeking to market as reducing the risk of specific smoking-related diseases ...
FDA headquarters, Maryland

FDA extends PMTA deadline by nearly four years

Written by Barnaby Page || 28th July 2017 || Regulatory briefing |

North America
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
The US Food and Drug Administration has taken a major step toward easing the demands of the deeming regulations, giving e-cig manufacturers nearly an extra four years to submit their...

FDA rejects snus as modified risk – but could reconsider some aspects

Written by Barnaby Page || 14th December 2016 || Regulatory briefing |

Europe
North America
Norway
Sweden
United States
Companies
Marketing and Retailing
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus products classified as modified risk – and they mix outright rejections with some very mild...

PMI bids to gain first ever FDA modified-risk approval for iQOS

Written by Barnaby Page || 6th December 2016 || Regulatory briefing |

North America
United States
Companies
Marketing and Retailing
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Regulatory briefing
Philip Morris International (PMI) this week submitted its iQOS technology for approval as a reduced-risk product by the U.S. Food and Drug Administration (FDA), a strategy which if successful would provide a tremendous boost to the credibility of...

Canadian government introduces long-expected e-cigarette bill

Written by Barnaby Page || 22nd November 2016 || Regulatory briefing |

Canada
North America
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
Canada’s government today made its long-awaited move to end regulatory confusion with a new bill which puts vapour products in a category of their own, distinct from conventional...

With Trump in the White House, is Cole-Bishop necessary?

Written by Barnaby Page || 18th November 2016 || Regulatory briefing |

North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
While many in the U.S. e-cigarette world hope that the Cole-Bishop proposal to change the FDA’s grandfathering date could be the industry’s salvation, at least one commentator believes it should be abandoned in the light of Donald Trump’s...

WHO stands firm on e-cigs, urges nations to consider prohibition

Written by Barnaby Page || 15th November 2016 || Regulatory briefing |

Africa
Asia
Europe
India
Mozambique
United Kingdom
World
Policy and Politics
Public Health and Medicine
Regulatory briefing
The World Health Organization (WHO) showed no signs of softening in its attitude toward reduced-risk products as its biannual tobacco control conference came to a close in...

Infographic: U.S. state legislatures focus on key e-cigarette issues

Written by Barnaby Page || 14th October 2016 || Regulatory briefing |

North America
United States
Marketing and Retailing
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
State legislatures in the U.S. continue to have numerous e-cigarette-related bills placed before them. Totting up the topics of those proposed laws reveals that some issues remain major concerns at state level, while others seemingly don’t trouble...

TPD poses tricky problems for small vape retailers in Netherlands

Written by Barnaby Page || 6th October 2016 || Business briefing |

Europe
Netherlands
Marketing and Retailing
Regulation and Legislation
Business briefing
The e-cigarette market in the Netherlands faces a serious challenge adapting to the requirements of the EU Tobacco Products Directive (TPD), as small specialist retailers try to cope with advertising restrictions, e-liquid regulations and age...

Smoking, vaping, free will, demonic possession and tax

Written by Barnaby Page || 2nd September 2016 || Regulatory briefing |

North America
Policy and Politics
Public Health and Medicine
Regulatory briefing
Nearly all smokers would be better off moving to lower-risk alternatives than giving up nicotine completely; taxing e-cigs has no rational justification; society should be prepared for more non-smokers to take up vaping; and tobacco control is often...

FDA: deeming regs are reasonable, legal challenges are unfounded

Written by Barnaby Page || 22nd August 2016 || Regulatory briefing |

North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
The U.S. Food and Drug Administration (FDA) has asked a judge to throw out the consolidated case against its deeming regulations, arguing that the new rules for e-cigarettes were arrived at reasonably and that requiring them is within...

TPD compliance: what to test and how to test it

Written by Barnaby Page || 17th August 2016 || Regulatory reports |

EU
Europe
Regulation and Legislation
Technology and Innovation
Regulatory reports
The EU’s Tobacco Products Directive (TPD) demands that manufacturers supply information on the ingredients and components of e-cig products, as well as testing ingredients and carrying out toxicological assessments – but it is vague on the detail of...

Nicoventures building up collection of safe flavour ingredients

Written by Barnaby Page || 15th August 2016 || Business briefing |

Europe
United Kingdom
Companies
Regulation and Legislation
Technology and Innovation
Business briefing
Nicoventures, the e-cig arm of British American Tobacco (BAT), is putting together a proprietary “toolbox” of pre-tested flavour ingredients for e-liquid to help it deal with the world’s rapidly changing regulatory...
Page 1 of 1112345...10...Last »